Liquidia CMO's Recent Stock Sales Highlight RSU Settlements Amid Strong Performance
Dr. Rajeev Saggar, Chief Medical Officer at Liquidia Corp (NASDAQ:LQDA), executed a series of stock sales totaling $709,816 between July 10 and July 13, 2026. These transactions were primarily related to the settlement of restricted stock units (RSUs) and performance stock units (PSUs), conducted under a Rule 10b5-1 trading plan established in Dece…